APA (7th ed.) Citation

AP, B., N, K., T, S., SJ, R., C, P., M, K., . . . TA, E. (2023). Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib. Haematologica, 108(5), 1429. https://doi.org/10.3324/haematol.2022.281402

Chicago Style (17th ed.) Citation

AP, Bye, et al. "Pirtobrutinib Results in Reversible Platelet Dysfunction Compared to Ibrutinib and Acalabrutinib." Haematologica 108, no. 5 (2023): 1429. https://doi.org/10.3324/haematol.2022.281402.

MLA (9th ed.) Citation

AP, Bye, et al. "Pirtobrutinib Results in Reversible Platelet Dysfunction Compared to Ibrutinib and Acalabrutinib." Haematologica, vol. 108, no. 5, 2023, p. 1429, https://doi.org/10.3324/haematol.2022.281402.